Creative Planning Pfizer Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Pfizer Inc stock. As of the latest transaction made, Creative Planning holds 1,820,731 shares of PFE stock, worth $45.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,820,731

Previous 1,554,564 17.12%

Holding current value

$45.4 Million

Previous $43.5 Million 21.14%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$27.7 - $31.39 $7.37 Million - $8.35 Million	266,167 Added 17.12%	1,820,731 $52.7 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $4.62 Million - $5.42 Million	182,950 Added 13.34%	1,554,564 $43.5 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $271,534 - $311,808	10,488 Added 0.77%	1,371,614 $38.1 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2.9 Million - $3.76 Million	-110,898 Reduced 7.53%	1,361,126 $39.2 Million
Q3 2023 Nov 16, 2023	BUY	$32.09 - $37.51 $1.95 Million - $2.28 Million	60,660 Added 4.3%	1,472,024 $48.8 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $2.27 Million - $2.63 Million	62,912 Added 4.67%	1,411,364 $51.8 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $398,075 - $518,235	10,106 Added 0.76%	1,348,452 $55 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $3.44 Million - $4.49 Million	82,401 Added 6.56%	1,338,346 $68.6 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $672,897 - $821,439	-15,377 Reduced 1.21%	1,255,945 $55 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $6.52 Million - $7.73 Million	140,167 Added 12.39%	1,271,322 $66.7 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $3.2 Million - $3.96 Million	69,894 Added 6.59%	1,131,155 $58.6 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $546,498 - $810,092	13,226 Added 1.26%	1,061,261 $62.7 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $695,981 - $894,047	-17,732 Reduced 1.66%	1,048,035 $45.1 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $2.86 Million - $3.24 Million	79,653 Added 8.08%	1,065,767 $41.7 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $1.77 Million - $2 Million	-52,879 Reduced 5.09%	986,114 $35.7 Million
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $3 Million - $3.81 Million	89,559 Added 9.43%	1,038,993 $38.2 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $2.87 Million - $3.37 Million	90,470 Added 10.53%	949,434 $34.8 Million
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $610,381 - $740,483	20,265 Added 2.42%	858,964 $28.1 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $912,613 - $1.3 Million	-33,763 Reduced 3.87%	838,699 $27.4 Million
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $827,246 - $938,819	-25,129 Reduced 2.8%	872,462 $34.2 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $604,411 - $783,744	-18,603 Reduced 2.03%	897,591 $32.3 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $19,488 - $21,881	-527 Reduced 0.06%	916,194 $39.7 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $81,937 - $90,022	-2,185 Reduced 0.24%	916,721 $38.9 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $438,134 - $499,521	-11,389 Reduced 1.22%	918,906 $40.1 Million
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $2.97 Million - $3.6 Million	86,097 Added 10.2%	930,295 $41 Million
Q2 2018 Jul 20, 2018	BUY	$32.98 - $35.16 $2.03 Million - $2.17 Million	61,690 Added 7.88%	844,198 $30.6 Million
Q1 2018 Apr 18, 2018	BUY	$31.91 - $37.02 $313,707 - $363,943	9,831 Added 1.27%	782,508 $27.8 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $908,829 - $964,299	27,325 Added 3.67%	772,677 $28 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $23.1 Million - $25.5 Million	745,352	745,352 $26.6 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Pfizer Inc Transaction History